Video Latest - ecancer

Update on targeted therapies for Philadelphia-like ALL

Prof Stephen Hunger - Children’s Hospital of Philadelphia, Philadelphia, USA

18 Oct 2018

Editor’s Choice for September 2018

Prof Gordon McVie - Founding Editor, ecancer

28 Sep 2018

Editor's Choice for August 2018

Prof Gordon McVie - Founding Editor, ecancer

22 Aug 2018

New important compounds for targeted and immunotherapies for lung cancer

Dr Christian Rolfo - Univeristy of Maryland, Baltimore, USA

7 Aug 2018

Updates from a range of lung cancer studies

Prof Edgardo S. Santos - Lynn Cancer Institute, Boca Raton, USA

7 Aug 2018

Rare mutations in non small cell lung cancer

Dr Tom Stinchcombe - Duke Cancer Institute, Durham, USA

7 Aug 2018

Several important studies for lung cancer

Prof Luis Raez - Herbert Wertheim College of Medicine, Miami, USA

7 Aug 2018

Key advances in ALL and AML

Dr Martin S. Tallman - Moffitt Cancer Center, Tampa, USA

7 Aug 2018

Extended genetic testing and GYN cancer risk

Dr Zoe Kemp - The Royal Marsden NHS Foundation Trust, London, UK

18 Jul 2018

Gynaecology highlights from ASCO 2018

Prof Christina Fotopoulou - Imperial College London Healthcare Trust, London, UK

12 Jul 2018

ASCO highlights: Bevacizumab for relapsed ovarian cancer

Prof Jonathan Ledermann - University College London Hospitals, London, UK

12 Jul 2018

Unexpected role for Immuno-oncology in SCCOHT

Dr Douglas Levine - NYU Langone Medical Center, New York, USA

12 Jul 2018

Video